LOL, let me rethink this...managed to confuse myself now.Even I am forgetting to add cash on hand into the value (which is a good thing for either valuation).
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%